» Articles » PMID: 32951136

An Opioid-Sparing Protocol Improves Recovery Time and Reduces Opioid Use After Laparoscopic Sleeve Gastrectomy

Overview
Journal Obes Surg
Date 2020 Sep 20
PMID 32951136
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The current literature is sparse on post discharge pain management for bariatric surgical patients. This study aimed to determine if an opioid-sparing protocol could decrease opioid use during the postoperative period (hospital to home).

Materials And Methods: In this retrospective cohort study, we implemented an opioid-sparing protocol in January 2018, for patients undergoing laparoscopic sleeve gastrectomy (LSG) at our institution. We compared recovery time, pain scores (in hospital and at home), and perioperative opioid use between the historic control group (February 2017 to December 2017) and the opioid-sparing group (January 2018 to December 2018). A p value of < .05 was considered statistically significant.

Results: The study included 400 patients (200 in each group), and 165 participated in the phone survey. Baseline characteristics were similar, except the control group had a higher body mass index and body weight. The average recovery time was significantly shorter in the opioid-sparing group (18.9 versus 35.3 days, P = .043). There was no significant difference in mean postoperative pain scores in the hospital or at home. The opioid-sparing group required significantly fewer opioids postoperatively (10.4 versus 16.1 morphine milligram equivalents, P < .001). Only 1 out of the 200 patients in the opioid-sparing arm requested an opioid prescription after discharge.

Conclusion: Implementation of an opioid-sparing protocol improved recovery time and reduced postoperative opioid use in the hospital and after discharge without changing perceived pain in patients undergoing LSG.

Citing Articles

Opioid Analgesics after Bariatric Surgery: A Scoping Review to Evaluate Physiological Risk Factors for Opioid-Related Harm.

Wuyts S, Torensma B, Schellekens A, Kramers C J Clin Med. 2023; 12(13).

PMID: 37445331 PMC: 10342511. DOI: 10.3390/jcm12134296.


Opioid Use After Gastric Bypass, Sleeve Gastrectomy or Intensive Lifestyle Intervention.

Wallen S, Bruze G, Ottosson J, Marcus C, Sundstrom J, Szabo E Ann Surg. 2023; 277(3):e552-e560.

PMID: 36700782 PMC: 9905206. DOI: 10.1097/SLA.0000000000005192.


Implementation of a standardized multimodal pain regimen significantly reduces postoperative inpatient opioid utilization in patients undergoing bariatric surgery.

Tan W, Ford J, Kindel T, Higgins R, Lak K, Gould J Surg Endosc. 2022; 37(4):3103-3112.

PMID: 35927346 DOI: 10.1007/s00464-022-09482-6.

References
1.
Hill M, McMahon M, Stucke R, Barth Jr R . Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Ann Surg. 2016; 265(4):709-714. DOI: 10.1097/SLA.0000000000001993. View

2.
Bicket M, Long J, Pronovost P, Alexander G, Wu C . Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review. JAMA Surg. 2017; 152(11):1066-1071. PMC: 5701659. DOI: 10.1001/jamasurg.2017.0831. View

3.
Friedman D, Ghiassi S, Hubbard M, Duffy A . Postoperative Opioid Prescribing Practices and Evidence-Based Guidelines in Bariatric Surgery. Obes Surg. 2019; 29(7):2030-2036. DOI: 10.1007/s11695-019-03821-8. View

4.
Brethauer S, Grieco A, Fraker T, Evans-Labok K, Smith A, McEvoy M . Employing Enhanced Recovery Goals in Bariatric Surgery (ENERGY): a national quality improvement project using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Surg Obes Relat Dis. 2019; 15(11):1977-1989. DOI: 10.1016/j.soard.2019.08.024. View

5.
Ahmed O, Rogers A, Bolger J, Mastrosimone A, Robb W . Meta-Analysis of Enhanced Recovery Protocols in Bariatric Surgery. J Gastrointest Surg. 2018; 22(6):964-972. DOI: 10.1007/s11605-018-3709-x. View